日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Unlocking the Power of CXCR2 Inhibition to Overcome Gemcitabine Resistance in Pancreatic Cancer.

释放 CXCR2 抑制剂的强大作用,克服胰腺癌吉西他滨耐药性。

Molczyk Caitlin, Sturgeon Reegan, Saxena Sugandha, Johnson Esther, Bhatia Rakesh, Bhyravbhatla Namita, Kumar Sushil, Batra Surinder K, Singh Rakesh K

Neutrophil Dynamics Contribute to Disease Progression and Poor Survival in Pancreatic Cancer.

中性粒细胞动态变化与胰腺癌的疾病进展和不良生存率相关。

Sturgeon Reegan, Goel Paran, Molczyk Caitlin, Bhola Ridhi, Grandgenett Paul M, Hollingsworth Michael A, Singh Rakesh K

The CXCR1 as a putative marker for cancer stem cell-like phenotypes in chemotherapy-resistant pancreatic ductal adenocarcinoma

CXCR1作为化疗耐药性胰腺导管腺癌中癌症干细胞样表型的潜在标志物

Molczyk, Caitlin; Sturgeon, Reegan; Thomas, Elizabeth; Singh, Rakesh K

Unlocking the Power of CXCR2 Inhibition to Overcome Gemcitabine Resistance in Pancreatic Cancer

释放 CXCR2 抑制剂的强大作用,克服胰腺癌吉西他滨耐药性

Molczyk, Caitlin; Sturgeon, Reegan; Saxena, Sugandha; Johnsson, Esther; Bhatia, Rakesh; Bhyrabhatla, Namita; Kumar, Sushil; Batra, Surinder K; Singh, Rakesh K

Small molecule antagonist of CXCR2 and CXCR1 inhibits tumor growth, angiogenesis, and metastasis in pancreatic cancer.

CXCR2 和 CXCR1 的小分子拮抗剂可抑制胰腺癌的肿瘤生长、血管生成和转移

Prajapati Dipakkumar R, Molczyk Caitlin, Purohit Abhilasha, Saxena Sugandha, Sturgeon Reegan, Dave Bhavana J, Kumar Sushil, Batra Surinder K, Singh Rakesh K

CXCR1: A Cancer Stem Cell Marker and Therapeutic Target in Solid Tumors

CXCR1:实体瘤中的癌症干细胞标志物和治疗靶点

Molczyk, Caitlin; Singh, Rakesh K